Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy

OBJECTIVE: There is a lack of effective treatment to improve the prognosis of intrahepatic cholangiocarcinoma (ICC). Programmed cell death protein-1 (PD-1)-targeted immunotherapy has shown promising results in a variety of malignant tumours. However, in patients with advanced ICC, the safety and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Min, Li, Shaohua, Wang, Qiaoxuan, Zhao, Rongce, Zou, Jingwen, Lin, Wenping, Mei, Jie, Wei, Wei, Guo, Rongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920361/
https://www.ncbi.nlm.nih.gov/pubmed/35272564
http://dx.doi.org/10.1080/07853890.2022.2048416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920361/
https://www.ncbi.nlm.nih.gov/pubmed/35272564
http://dx.doi.org/10.1080/07853890.2022.2048416

Ejemplares similares